Advertisement

Ads Placeholder
Loading...

Omnicell, Inc.

OMCLNASDAQ
Healthcare
Medical - Healthcare Information Services
$34.15
$0.21(0.62%)
U.S. Market opens in 22h 24m

Omnicell, Inc. (OMCL) Stock Overview

Explore Omnicell, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.6B
P/E Ratio748.22
EPS (TTM)$0.04
ROE0.00%
Fundamental Analysis

AI Price Forecasts

1 Month$33.16
3 Months$25.82
1 Year Target$37.75

OMCL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Omnicell, Inc. (OMCL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 40.43, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $37.75.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 748.22 and a market capitalization of 1.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.62%
5-Day Change
-1.47%
1-Month Change
-16.30%
3-Month Change
-24.35%
6-Month Change
10.34%
Year-to-Date (YTD) Change
-24.35%
1-Year Change
0.32%
3-Year Change
-41.11%
5-Year Change
-74.34%
All-Time (Max) Change
289.84%

Contact Information

650 251 6100
590 East Middlefield Road, Mountain View, CA, 94043

Company Facts

36,200 Employees
IPO DateAug 9, 2001
CountryUS
Actively Trading

Frequently Asked Questions